U.S. Markets close in 4 hrs 39 mins

Health Canada to keep importing Kaleo's epinephrine shot amid shortages

July 19 (Reuters) - Canadian health regulator said on Friday it will keep importing U.S.-based Kaleo Inc's epinephrine auto-injectors and expects adequate supply of the devices in the country over the coming months.

Health Canada's announcement comes after Pfizer Inc, that makes Mylan NV's EpiPens sold globally, notified that a shortage of the 0.3 mg dose of the emergency allergy shots may lead to temporary supply constraints in Canada. (Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Shailesh Kuber)